Messenger of Death

  • ChemPubSoc Europe Logo
  • Author: Anne Deveson
  • Published Date: 21 January 2016
  • Source / Publisher: Chemistry – A European Journal/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: Messenger of Death

Related Societies

Breast cancer is the most commonly diagnosed malignancy and the deadliest among women worldwide. An interesting field in cancer-fighting research is immunotherapy, which does not aim to directly eliminate cancer cells, but to activate and enhance the immune system's action against tumours.


In this field, Ramón Martínez-Máñez, University of València, Spain, Ana M. Jiménez-Lara, Instituto de Investigaciones Biomédicas A. Sols CSIC-UAM, Spain, and their collaborators are interested in the use of ligands for Toll-like receptors (TLRs) to potentiate immune stimulatory pathways. They designed a delivery system based on mesoporous silica nanoparticles capped with synthetic double stranded RNA (dsRNA) polyinosinic–polycytidylic acid. The nanoparticles were loaded with doxorubicin, a commonly used chemotherapeutic agent.


The team found that these dsRNA-conjugated nanoparticles can effectively target TLR3-expressing breast cancer cells. They cause a TLR3-mediated internalization of the nanoparticles that correlates with a caspase-dependent apoptosis (cell death) induction.


 

Article Views: 1987

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH